N
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
Price:
29.44
USD
-3.79%
Market Closed
Market Cap:
$3.4B
Cash Flow Statement
Cash Flow Statement
NewAmsterdam Pharma Company NV
NewAmsterdam Pharma Company NV
Currency: EUR
| Jun-2022 | Sep-2022 | Dec-2022 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
4
|
(4)
|
(78)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
4
|
|
| Other Non-Cash Items |
(7)
|
(0)
|
75
|
|
| Cash Interest Paid |
0
|
0
|
0
|
|
| Change in Working Capital |
2
|
4
|
11
|
|
| Cash from Operating Activities |
(1)
N/A
|
(0)
+69%
|
8
N/A
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
0
|
0
|
(0)
|
|
| Other Items |
0
|
0
|
1
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
1
N/A
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
0
|
0
|
378
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
|
| Other |
(0)
|
(0)
|
(3)
|
|
| Cash from Financing Activities |
(0)
N/A
|
(0)
N/A
|
375
N/A
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
0
|
0
|
2
|
|
| Net Change in Cash |
(1)
N/A
|
(0)
+65%
|
385
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
(1)
N/A
|
(0)
+69%
|
8
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
